Supplementary Figure 9: Regional recurrence analysis on individual tumor types compared to a pan-cancer cohort.
From: Genome-wide analysis of noncoding regulatory mutations in cancer
Regional recurrence analysis on six subsets of the total data set (astr, brca, brain (lgg + gbm), lihc, luad and medu) identifies potential cancer-specific candidates, such as the PADI2-PADI4 enhancer.
